Dry Eye

Customer Success Stories: Celebrating Your Big Wins in 2014-2015
SkQ1 is the first mitochondria-targeted antioxidant to reach clinical phase of development for an ophthalmic indication
U.S. joint venture with G-treeBNT (ReGenTree LLC) has retained Ora, Inc.
Original Research
Herantis Pharma’s Phase 2 Dry Eye study recruitment completed ahead of schedule
For 20 years, “Therapeutic Topics” has explored ocular disease. Here’s an update on where translational medicine stands today.
After three millennia of battling the discomfort and irritation of dry eye, is ophthalmology any closer to a solution?
Positive statistical correlations were identified
After three millennia of battling the discomfort and irritation of dry eye, is ophthalmology any closer to a solution?

Pages

Subscribe to Dry Eye